130 related articles for article (PubMed ID: 16024631)
1. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.
Fernández Y; Verhaegen M; Miller TP; Rush JL; Steiner P; Opipari AW; Lowe SW; Soengas MS
Cancer Res; 2005 Jul; 65(14):6294-304. PubMed ID: 16024631
[TBL] [Abstract][Full Text] [Related]
2. Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma.
Amiri KI; Horton LW; LaFleur BJ; Sosman JA; Richmond A
Cancer Res; 2004 Jul; 64(14):4912-8. PubMed ID: 15256463
[TBL] [Abstract][Full Text] [Related]
3. Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms.
Chen Z; Ricker JL; Malhotra PS; Nottingham L; Bagain L; Lee TL; Yeh NT; Van Waes C
Mol Cancer Ther; 2008 Jul; 7(7):1949-60. PubMed ID: 18645005
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors against amelanotic melanoma.
Sidor-Kaczmarek J; Cichorek M; Spodnik JH; Wójcik S; Moryś J
Cell Biol Toxicol; 2017 Dec; 33(6):557-573. PubMed ID: 28281027
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal Zn
Du W; Gu M; Hu M; Pinchi P; Chen W; Ryan M; Nold T; Bannaga A; Xu H
Cell Rep; 2021 Oct; 37(3):109848. PubMed ID: 34686351
[TBL] [Abstract][Full Text] [Related]
6. The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells.
Wiersma VR; de Bruyn M; van Ginkel RJ; Sigar E; Hirashima M; Niki T; Nishi N; Samplonius DF; Helfrich W; Bremer E
J Invest Dermatol; 2012 Sep; 132(9):2302-5. PubMed ID: 22572821
[No Abstract] [Full Text] [Related]
7. Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors.
Kim KB; Crews CM
J Med Chem; 2008 May; 51(9):2600-5. PubMed ID: 18393403
[No Abstract] [Full Text] [Related]
8. Kunitz type protease inhibitor from the canine tapeworm as a potential therapeutic for melanoma.
Ranasinghe SL; Rivera V; Boyle GM; McManus DP
Sci Rep; 2019 Nov; 9(1):16207. PubMed ID: 31700040
[TBL] [Abstract][Full Text] [Related]
9. In vivo detection of drug-induced apoptosis in tumors using Raman spectroscopy.
Jonas O; Kang JW; Singh SP; Lammers A; Nguyen FT; Dasari RR; So PTC; Langer R; Cima MJ
Analyst; 2018 Oct; 143(20):4836-4839. PubMed ID: 30070266
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening.
Shao F; Lyu X; Miao K; Xie L; Wang H; Xiao H; Li J; Chen Q; Ding R; Chen P; Xing F; Zhang X; Luo GH; Zhu W; Cheng G; Lon NW; Martin SE; Wang G; Chen G; Dai Y; Deng CX
Adv Sci (Weinh); 2020 Dec; 7(23):2001914. PubMed ID: 33304752
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells". [Cell Signal. 25(1)Jan 2013 308-18].
Selimovic D; Porzig BB; El-Khattouti A; Badura HE; Ahmad M; Ghanjati F; Santourlidis S; Haikel Y; Hassan M
Cell Signal; 2015 Feb; ():. PubMed ID: 25666930
[No Abstract] [Full Text] [Related]
12. Potential New Therapies "ROS-Based" in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis.
Sciaccotta R; Gangemi S; Penna G; Giordano L; Pioggia G; Allegra A
Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671922
[TBL] [Abstract][Full Text] [Related]
13. Increased Microtubule Growth Triggered by Microvesicle-mediated Paracrine Signaling is Required for Melanoma Cancer Cell Invasion.
Pudelko K; Wieland A; Hennecke M; Räschle M; Bastians H
Cancer Res Commun; 2022 May; 2(5):366-379. PubMed ID: 36875714
[TBL] [Abstract][Full Text] [Related]
14. BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis.
Roufayel R; Younes K; Al-Sabi A; Murshid N
Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207544
[TBL] [Abstract][Full Text] [Related]
15. Stress Granules in the Anti-Cancer Medications Mechanism of Action: A Systematic Scoping Review.
Asadi MR; Moslehian MS; Sabaie H; Poornabi M; Ghasemi E; Hassani M; Hussen BM; Taheri M; Rezazadeh M
Front Oncol; 2021; 11():797549. PubMed ID: 35004322
[TBL] [Abstract][Full Text] [Related]
16. Proteotoxic Stress and Cell Death in Cancer Cells.
Brancolini C; Iuliano L
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32842524
[TBL] [Abstract][Full Text] [Related]
17. AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA.
Mallick DJ; Eastman A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824203
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma cells are exceptionally sensitive to heat shock, which overwhelms their proteostasis network and induces apoptosis.
Sha Z; Goldberg AL
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21588-21597. PubMed ID: 32817432
[TBL] [Abstract][Full Text] [Related]
19. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.
Tundo GR; Sbardella D; Santoro AM; Coletta A; Oddone F; Grasso G; Milardi D; Lacal PM; Marini S; Purrello R; Graziani G; Coletta M
Pharmacol Ther; 2020 Sep; 213():107579. PubMed ID: 32442437
[TBL] [Abstract][Full Text] [Related]
20. NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and "osmotic reprogramming" in colorectal cancer.
Knoll G; Riffelsberger P; Raats D; Kranenburg O; Ehrenschwender M
Cell Death Dis; 2020 Apr; 11(4):257. PubMed ID: 32312973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
